Balance Sheet Align Technology, Inc.

Equities

ALGN

US0162551016

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Other stock markets 02:30:00 13/01/2026 am IST			5-day change	1st Jan Change
172.00 ^USD	-0.46%		+7.41%	+10.15%

07/01	Ai/Ml Innovations Inc. Appoints Erik Suokas as Chief Operating Officer	CI
09/12	Align Technology, Inc. Announces Invisalign System with Mandibular Advancement Featuring Occlusal Blocks for Class II Skeletal and Dental Correction	CI

ccd14a432b30872.LjvIQuKswP8oJNsD-vtBLJA7sUbRcdf41t9qlaV-3ns.dlyFO9Dnusp_SpBmjZ0tYtNz2gyBO4i-oJIPrM45vDNaTIwWz_ahsGF7mg

Published financial data: ALIGN TECHNOLOGY, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	247.19Cr	395.26Cr	373.46Cr	386.23Cr	399.9Cr
Total Revenues	247.19Cr	395.26Cr	373.46Cr	386.23Cr	399.9Cr
Cost of Goods Sold, Total	71Cr	101.72Cr	109.8Cr	115.47Cr	119.61Cr
Gross Profit	176.32Cr	293.54Cr	263.67Cr	270.76Cr	280.3Cr
Selling General & Admin Expenses, Total	120.08Cr	170.86Cr	167.45Cr	170.34Cr	176.32Cr
R&D Expenses	18Cr	25Cr	31Cr	35Cr	36Cr
Other Operating Expenses	-	-	53T	-	-
Other Operating Expenses, Total	137.61Cr	195.9Cr	197.98Cr	205.02Cr	212.74Cr
Operating Income	39Cr	98Cr	66Cr	66Cr	68Cr
Interest And Investment Income	31.25L	31.03L	53.67L	1.73Cr	2.02Cr
Net Interest Expenses	31.25L	31.03L	53.67L	1.73Cr	2.02Cr
Income (Loss) On Equity Invest.	-	-	-	-	-
Currency Exchange Gains (Loss)	68L	-1.33Cr	-4.38Cr	-70L	-2.1Cr
Other Non Operating Income (Expenses)	-20.6L	28.17L	-51.05L	-74.02L	-78.72L
EBT, Excl. Unusual Items	40Cr	97Cr	61Cr	66Cr	67Cr
Restructuring Charges	-	-	-1.02Cr	-1.4Cr	-3.7Cr
Merger & Related Restructuring Charges	-1.02Cr	-	-	-	-
Gain (Loss) On Sale Of Investments	-58.87L	-	-	-49.9L	99.85L
Asset Writedown	-	-	-18L	-	-
Legal Settlements	-	4.34Cr	-	-	-3.1Cr
Other Unusual Items	-	-	-23L	-	-
EBT, Incl. Unusual Items	38Cr	101.24Cr	60Cr	64Cr	61Cr
Income Tax Expense	-139.69Cr	24Cr	24Cr	20Cr	19Cr
Earnings From Continuing Operations	177.59Cr	77Cr	36Cr	45Cr	42Cr
Net Income to Company	177.59Cr	77Cr	36Cr	45Cr	42Cr
Net Income - (IS)	177.59Cr	77Cr	36Cr	45Cr	42Cr
Net Income to Common Incl Extra Items	177.59Cr	77Cr	36Cr	45Cr	42Cr
Net Income to Common Excl. Extra Items	177.59Cr	77Cr	36Cr	45Cr	42Cr
Per Share Items
Net EPS - Basic	22.55	9.78	4.62	5.82	5.63
Basic EPS - Continuing Operations	22.55	9.78	4.62	5.82	5.63
Basic Weighted Average Shares Outstanding	7.88Cr	7.89Cr	7.82Cr	7.64Cr	7.49Cr
Net EPS - Diluted	22.41	9.69	4.61	5.81	5.62
Diluted EPS - Continuing Operations	22.41	9.69	4.61	5.81	5.62
Diluted Weighted Average Shares Outstanding	7.92Cr	7.97Cr	7.84Cr	7.66Cr	7.5Cr
Normalized Basic EPS	3.13	7.67	4.9	5.4	5.57
Normalized Diluted EPS	3.12	7.6	4.89	5.39	5.56
American Depositary Receipts Ratio (ADR)	0.25	0.25	0.25	0.25	0.25
Supplemental Items
EBITDA	48Cr	108.51Cr	78Cr	80Cr	82Cr
EBITA	40Cr	99Cr	67Cr	67Cr	69Cr
EBIT	39Cr	98Cr	66Cr	66Cr	68Cr
EBITDAR	51Cr	112.95Cr	84Cr	86Cr	87Cr
Effective Tax Rate - (Ratio)	-368.64	23.75	39.64	30.59	30.81
Current Domestic Taxes	6.42Cr	19Cr	22Cr	16Cr	11Cr
Current Foreign Taxes	2.94Cr	4.27Cr	5.65Cr	5.13Cr	5.67Cr
Total Current Taxes	9.36Cr	23Cr	28Cr	21Cr	17Cr
Deferred Domestic Taxes	-1.39Cr	-3.15Cr	-6.78Cr	-2Cr	49.62L
Deferred Foreign Taxes	-147.66Cr	4.34Cr	2.61Cr	19.4L	1.73Cr
Total Deferred Taxes	-149.05Cr	1.2Cr	-4.17Cr	-1.8Cr	2.22Cr
Normalized Net Income	25Cr	61Cr	38Cr	41Cr	42Cr
Supplemental Operating Expense Items
Advertising Expense	16Cr	33Cr	-	20Cr	18Cr
Selling and Marketing Expenses	16Cr	33Cr	-	20Cr	18Cr
Research And Development Expense From Footnotes	18Cr	25Cr	31Cr	35Cr	36Cr
Net Rental Expense, Total	2.93Cr	4.44Cr	6Cr	6.06Cr	4.59Cr
Stock-Based Comp., COGS (Total)	47.19L	56.33L	64.38L	74.62L	69.95L
Stock-Based Comp., R&D Exp. (Total)	1.52Cr	1.8Cr	2.38Cr	3.06Cr	4.27Cr
Stock-Based Comp., SG&A Exp. (Total)	7.85Cr	9.07Cr	10Cr	12Cr	12Cr
Total Stock-Based Compensation	9.84Cr	11Cr	13Cr	15Cr	17Cr

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	96Cr	109.94Cr	94Cr	94Cr	104.39Cr
Short Term Investments	-	7.2Cr	5.75Cr	3.53Cr	-
Total Cash And Short Term Investments	96Cr	117.13Cr	100Cr	97Cr	104.39Cr
Accounts Receivable, Total	66Cr	90Cr	86Cr	90Cr	100Cr
Other Receivables	4.52Cr	-	14Cr	14Cr	3.4Cr
Notes Receivable	54.08L	-	-	-	-
Total Receivables	71Cr	90Cr	100.02Cr	104.72Cr	102.97Cr
Inventory	14Cr	23Cr	34Cr	30Cr	25Cr
Prepaid Expenses	1.4Cr	7.02Cr	6.91Cr	5.25Cr	8.3Cr
Restricted Cash	-	-	-	-	-
Other Current Assets, Total	2.71Cr	13Cr	1.68Cr	7.73Cr	8.16Cr
Total Current Assets	184.95Cr	249.41Cr	242.44Cr	244.66Cr	249.24Cr
Gross Property Plant And Equipment	111.85Cr	156.23Cr	180.05Cr	195.96Cr	204.62Cr
Accumulated Depreciation	-30Cr	-36Cr	-45Cr	-55Cr	-66Cr
Net Property Plant And Equipment	82Cr	120.32Cr	135.07Cr	140.89Cr	138.45Cr
Long-term Investments	-	13Cr	4.2Cr	80.22L	-
Goodwill	44Cr	42Cr	41Cr	42Cr	44Cr
Other Intangibles, Total	13Cr	11Cr	9.57Cr	8.21Cr	10Cr
Loans Receivable Long-Term	-	-	-	-	-
Deferred Tax Assets Long-Term	155.28Cr	153.38Cr	157.17Cr	159Cr	155.74Cr
Deferred Charges Long-Term	2.28Cr	3.11Cr	2.74Cr	2.51Cr	2.58Cr
Other Long-Term Assets, Total	1.24Cr	1.78Cr	2.84Cr	10Cr	21Cr
Total Assets	482.97Cr	594.21Cr	594.79Cr	608.39Cr	621.46Cr
Liabilities
Accounts Payable, Total	14Cr	16Cr	13Cr	11Cr	11Cr
Accrued Expenses, Total	31Cr	49Cr	32Cr	43Cr	47Cr
Current Portion of Leases	2.17Cr	2.27Cr	2.66Cr	2.97Cr	3.11Cr
Current Income Taxes Payable	3.01Cr	3.38Cr	7.43Cr	3.81Cr	4.88Cr
Unearned Revenue Current, Total	78Cr	115.29Cr	134.36Cr	142.77Cr	133.11Cr
Other Current Liabilities	4.03Cr	6.27Cr	3.78Cr	2.36Cr	4.47Cr
Total Current Liabilities	132.56Cr	192.41Cr	192.59Cr	206.66Cr	203.8Cr
Long-Term Leases	6.44Cr	10Cr	10Cr	9.7Cr	8.82Cr
Unearned Revenue Non Current	6.26Cr	14Cr	16Cr	14Cr	10Cr
Other Non Current Liabilities	14Cr	16Cr	16Cr	15Cr	13Cr
Total Liabilities	159.58Cr	231.94Cr	234.66Cr	245.34Cr	236.26Cr
Common Stock, Total	8T	8T	8T	7T	7T
Additional Paid In Capital	97Cr	100Cr	104.49Cr	116.21Cr	136.22Cr
Retained Earnings	221.58Cr	261.94Cr	256.67Cr	244.72Cr	248.38Cr
Comprehensive Income and Other	4.35Cr	43.26L	-1.03Cr	2.12Cr	59.78L
Total Common Equity	323.39Cr	362.27Cr	360.14Cr	363.05Cr	385.2Cr
Total Equity	323.39Cr	362.27Cr	360.14Cr	363.05Cr	385.2Cr
Total Liabilities And Equity	482.97Cr	594.21Cr	594.79Cr	608.39Cr	621.46Cr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	7.91Cr	7.88Cr	7.66Cr	7.51Cr	7.36Cr
ECS Total Common Shares Outstanding	7.89Cr	7.87Cr	7.73Cr	7.51Cr	7.38Cr
Book Value / Share	41.01	46.03	46.61	48.36	52.16
Tangible Book Value	265.9Cr	309.45Cr	309.81Cr	312.88Cr	330.59Cr
Tangible Book Value Per Share	33.72	39.31	40.1	41.68	44.77
Total Debt	8.62Cr	13Cr	13Cr	13Cr	12Cr
Net Debt	-87Cr	-117.13Cr	-91Cr	-85Cr	-92Cr
Debt Equivalent Oper. Leases	23Cr	36Cr	48Cr	49Cr	37Cr
Equity Method Investments, Total	-	-	-	-	-
Account Code - Inventory Valuation	3	5	5	5	5
Inventories - Raw Materials, Total	7.64Cr	12Cr	17Cr	15Cr	12Cr
Inventories - Work In Process, Total	3.14Cr	5.17Cr	9.66Cr	9.13Cr	7.37Cr
Inventories - Finished Goods, Total	3.14Cr	5.53Cr	6.94Cr	6.02Cr	5.62Cr
Land - (BS)	3.46Cr	5.89Cr	5.89Cr	6.39Cr	6.39Cr
Buildings, Total	24Cr	31Cr	47Cr	52Cr	53Cr
Machinery, Total	47Cr	52Cr	69Cr	83Cr	100.76Cr
Full Time Employees	18.07T	22.54T	23.16T	21.61T	20.94T
Accumulated Allowance for Doubtful Accounts (Supple)	1.02Cr	92.45L	1.03Cr	1.49Cr	1.91Cr
Order Backlog	87Cr	-	-	-	-

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	177.59Cr	77Cr	36Cr	45Cr	42Cr
Depreciation & Amortization - CF	8.01Cr	9.21Cr	11Cr	13Cr	13Cr
Amortization of Goodwill and Intangible Assets - (CF)	1.34Cr	1.66Cr	1.6Cr	1.64Cr	1.89Cr
Depreciation & Amortization, Total	9.35Cr	11Cr	13Cr	14Cr	15Cr
(Gain) Loss on Sale of Investments - (CF)	58.87L	-	-	49.9L	-58.85L
Asset Writedown & Restructuring Costs	-	-	-	-	-
(Income) Loss On Equity Investments - (CF)	-	-	-	-	-
Stock-Based Compensation (CF)	9.84Cr	11Cr	13Cr	15Cr	17Cr
Tax Benefit from Stock Options	-	-	-	-	-
Provision and Write-off of Bad Debts	1.21Cr	28.14L	-	-	-
Other Operating Activities, Total	-145.33Cr	2.04Cr	3.23Cr	4.72Cr	7.64Cr
Change In Accounts Receivable	-14Cr	-26Cr	2.15Cr	-10Cr	-15Cr
Change In Inventories	-2.91Cr	-11Cr	-13Cr	3.02Cr	2.51Cr
Change In Accounts Payable	5.22Cr	1.97Cr	-3.65Cr	-77.03L	-8L
Change in Unearned Revenues	23Cr	46Cr	24Cr	8.67Cr	-8.01Cr
Change In Income Taxes	-28.02L	1.24Cr	63.27L	-77.72L	-2.03Cr
Change in Other Net Operating Assets	2.1Cr	3.39Cr	-19Cr	-46.86L	16Cr
Cash from Operations	66Cr	117.25Cr	57Cr	79Cr	74Cr
Capital Expenditure	-15Cr	-40Cr	-29Cr	-18Cr	-12Cr
Cash Acquisitions	-42Cr	-80.02L	-1.23Cr	-	-7.71Cr
Investment in Marketable and Equity Securities, Total	32Cr	-20Cr	9.31Cr	-1.85Cr	-6.25Cr
Other Investing Activities, Total	2.81Cr	4.3Cr	-22.11L	3L	2L
Cash from Investing	-23Cr	-56Cr	-21Cr	-20Cr	-25Cr
Long-Term Debt Repaid, Total	-	-	-	-	-
Total Debt Repaid	-	-	-	-	-
Issuance of Common Stock	2.03Cr	2.56Cr	2.61Cr	2.66Cr	2.53Cr
Repurchase of Common Stock	-5.11Cr	-48Cr	-49Cr	-61Cr	-38Cr
Other Financing Activities, Total	-	-	-4Cr	-1Cr	-
Cash from Financing	-3.08Cr	-46Cr	-50Cr	-60Cr	-36Cr
Foreign Exchange Rate Adjustments	1.05Cr	-1.21Cr	-1.15Cr	46.71L	-2.12Cr
Net Change in Cash	41Cr	14Cr	-16Cr	-38.36L	11Cr
Supplemental Items
Cash Income Tax Paid (Refund)	7.63Cr	20Cr	23Cr	29Cr	18Cr
Levered Free Cash Flow	50Cr	60Cr	27Cr	62Cr	62Cr
Unlevered Free Cash Flow	50Cr	60Cr	27Cr	62Cr	62Cr
Change In Net Working Capital	-22Cr	-16Cr	10Cr	-8.86Cr	46.74L
Net Debt Issued / Repaid	-	-	-	-	-

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	6.6	11.33	6.91	6.83	6.87
Return on Total Capital	10.24	17.27	10.98	10.98	10.93
Return On Equity %	77.55	22.52	10.01	12.31	11.26
Return on Common Equity	77.55	22.52	10.01	12.31	11.26
Margin Analysis
Gross Profit Margin %	71.33	74.26	70.6	70.1	70.09
SG&A Margin	48.58	43.23	44.84	44.1	44.09
EBITDA Margin %	19.45	27.45	20.96	20.71	20.52
EBITA Margin %	16.2	25.12	18.02	17.44	17.37
EBIT Margin %	15.66	24.7	17.59	17.02	16.89
Income From Continuing Operations Margin %	71.84	19.53	9.68	11.52	10.54
Net Income Margin %	71.84	19.53	9.68	11.52	10.54
Net Avail. For Common Margin %	71.84	19.53	9.68	11.52	10.54
Normalized Net Income Margin	9.99	15.32	10.26	10.68	10.42
Levered Free Cash Flow Margin	20.38	15.07	7.33	16	15.52
Unlevered Free Cash Flow Margin	20.38	15.07	7.33	16	15.52
Asset Turnover
Asset Turnover	0.67	0.73	0.63	0.64	0.65
Fixed Assets Turnover	3.28	3.91	2.92	2.8	2.86
Receivables Turnover (Average Receivables)	4.09	5.08	4.25	4.38	4.21
Inventory Turnover (Average Inventory)	5.64	5.51	3.86	3.63	4.34
Short Term Liquidity
Current Ratio	1.4	1.3	1.26	1.18	1.22
Quick Ratio	1.26	1.08	1.04	0.98	1.02
Operating Cash Flow to Current Liabilities	0.5	0.61	0.3	0.38	0.36
Days Sales Outstanding (Average Receivables)	89.43	71.79	85.85	83.31	86.91
Days Outstanding Inventory (Average Inventory)	64.89	66.29	94.57	100.47	84.33
Average Days Payable Outstanding	57.04	50.39	44.13	39.52	35.19
Cash Conversion Cycle (Average Days)	97.27	87.68	136.3	144.25	136.05
Long Term Solvency
Total Debt/Equity	2.66	3.46	3.52	3.49	3.1
Total Debt / Total Capital	2.6	3.34	3.4	3.37	3
LT Debt/Equity	1.99	2.83	2.79	2.67	2.29
Long-Term Debt / Total Capital	1.94	2.74	2.69	2.58	2.22
Total Liabilities / Total Assets	33.04	39.03	39.45	40.33	38.02
Total Debt / EBITDA	0.17	0.11	0.15	0.15	0.14
Net Debt / EBITDA	-1.72	-1.04	-1.09	-0.99	-1.07
Total Debt / (EBITDA - Capex)	0.24	0.17	0.23	0.19	0.16
Net Debt / (EBITDA - Capex)	-2.46	-1.61	-1.66	-1.25	-1.23
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	2.71	59.9	-5.51	3.42	3.54
Gross Profit, 1 Yr. Growth %	1.11	66.48	-10.18	2.8	3.52
EBITDA, 1 Yr. Growth %	-19	125.74	-27.87	2.55	2.61
EBITA, 1 Yr. Growth %	-23.02	147.9	-32.24	0.55	3.07
EBIT, 1 Yr. Growth %	-24.75	152.19	-32.72	0.51	2.77
Earnings From Cont. Operations, 1 Yr. Growth %	301.08	-56.53	-53.17	23.09	-5.32
Net Income, 1 Yr. Growth %	301.08	-56.53	-53.17	23.09	-5.32
Normalized Net Income, 1 Yr. Growth %	-23.34	149.01	-36.7	8.14	1.01
Diluted EPS Before Extra, 1 Yr. Growth %	305.24	-56.76	-52.43	26.03	-3.27
Accounts Receivable, 1 Yr. Growth %	19.52	36.41	-4.18	5.09	10.21
Inventory, 1 Yr. Growth %	24.26	65.35	47.14	-12.35	-14.35
Net Property, Plant and Equip., 1 Yr. Growth %	18.79	47.22	12.26	4.3	-1.73
Total Assets, 1 Yr. Growth %	93.13	23.03	0.1	2.29	2.15
Tangible Book Value, 1 Yr. Growth %	109.29	16.38	0.12	0.99	5.66
Common Equity, 1 Yr. Growth %	140.23	12.02	-0.59	0.81	6.1
Cash From Operations, 1 Yr. Growth %	-11.39	77.07	-51.5	38.16	-6.05
Capital Expenditures, 1 Yr. Growth %	3.48	158.91	-27.22	-39.12	-34.96
Levered Free Cash Flow, 1 Yr. Growth %	24.54	18.24	-54.05	127.32	0.42
Unlevered Free Cash Flow, 1 Yr. Growth %	24.54	18.24	-54.05	127.32	0.42
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	12.12	28.15	22.92	-1.15	3.48
Gross Profit, 2 Yr. CAGR %	10.35	29.74	22.28	-3.96	3.16
EBITDA, 2 Yr. CAGR %	-3.97	35.22	27.6	-14.15	2.58
EBITA, 2 Yr. CAGR %	-7.93	38.14	29.61	-17.63	1.81
EBIT, 2 Yr. CAGR %	-8.9	37.76	30.26	-17.95	1.63
Earnings From Cont. Operations, 2 Yr. CAGR %	110.64	32.05	-54.88	-24.07	7.95
Net Income, 2 Yr. CAGR %	110.64	32.05	-54.88	-24.07	7.95
Normalized Net Income, 2 Yr. CAGR %	-7.12	37.66	25.54	-17.46	4.52
Diluted EPS Before Extra, 2 Yr. CAGR %	113.42	32.37	-54.64	-22.57	10.41
Accounts Receivable, 2 Yr. CAGR %	22.4	27.69	14.33	0.35	7.62
Inventory, 2 Yr. CAGR %	58.19	43.34	55.98	13.56	-13.36
Net Property, Plant and Equip., 2 Yr. CAGR %	25.21	32.25	28.56	8.21	1.24
Total Assets, 2 Yr. CAGR %	53.4	54.15	10.97	1.19	2.22
Tangible Book Value, 2 Yr. CAGR %	50.69	56.07	7.94	0.55	3.3
Common Equity, 2 Yr. CAGR %	60.66	64.05	5.53	0.11	3.42
Cash From Operations, 2 Yr. CAGR %	9.26	25.26	-7.32	-18.14	13.93
Capital Expenditures, 2 Yr. CAGR %	-16.71	63.68	37.27	-33.44	-37.07
Levered Free Cash Flow, 2 Yr. CAGR %	40.41	21.35	-26.29	1.87	51.08
Unlevered Free Cash Flow, 2 Yr. CAGR %	40.41	21.35	-26.29	1.87	51.08
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	18.82	26.2	15.77	16.04	0.39
Gross Profit, 3 Yr. CAGR %	16.44	26.56	14.77	15.37	-1.53
EBITDA, 3 Yr. CAGR %	6.54	27.68	9.66	18.49	-8.89
EBITA, 3 Yr. CAGR %	3.64	28.08	8.95	18.93	-11.24
EBIT, 3 Yr. CAGR %	3.07	27.91	8.49	19.3	-11.55
Earnings From Cont. Operations, 3 Yr. CAGR %	97.25	24.48	-6.53	-36.95	-18.28
Net Income, 3 Yr. CAGR %	97.25	24.48	-6.53	-36.95	-18.28
Normalized Net Income, 3 Yr. CAGR %	2.99	28.38	6.25	19.27	-11.71
Diluted EPS Before Extra, 3 Yr. CAGR %	99.32	25.35	-5.89	-36.24	-16.61
Accounts Receivable, 3 Yr. CAGR %	26.59	26.9	16.03	11.16	3.53
Inventory, 3 Yr. CAGR %	63.79	60.54	44.6	28.71	3.37
Net Property, Plant and Equip., 3 Yr. CAGR %	32.82	32.15	25.22	19.9	4.79
Total Assets, 3 Yr. CAGR %	39.37	42.52	33.49	8	1.51
Tangible Book Value, 3 Yr. CAGR %	35.65	38.26	34.6	5.57	2.23
Common Equity, 3 Yr. CAGR %	40.97	42.46	38.82	3.93	2.07
Cash From Operations, 3 Yr. CAGR %	14.72	28.34	-8.7	5.87	-14.29
Capital Expenditures, 3 Yr. CAGR %	-7.49	21.56	24.93	4.68	-33.95
Levered Free Cash Flow, 3 Yr. CAGR %	49.85	32.6	-12.21	7.06	1.38
Unlevered Free Cash Flow, 3 Yr. CAGR %	49.85	32.6	-12.21	7.06	1.38
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	23.93	29.63	20.44	14.45	10.69
Gross Profit, 5 Yr. CAGR %	22.46	29.2	18.74	13.34	9.96
EBITDA, 5 Yr. CAGR %	18.4	31.48	14.51	8.94	6.7
EBITA, 5 Yr. CAGR %	16.26	31.54	13.34	7.35	5.94
EBIT, 5 Yr. CAGR %	15.47	31.44	13.19	7.1	5.6
Earnings From Cont. Operations, 5 Yr. CAGR %	65.27	32.41	9.34	2.15	-0.99
Net Income, 5 Yr. CAGR %	65.27	32.41	9.34	2.15	-0.99
Normalized Net Income, 5 Yr. CAGR %	16.25	32.1	11.15	7.59	5.46
Diluted EPS Before Extra, 5 Yr. CAGR %	66.15	32.98	10.25	3.38	0.32
Accounts Receivable, 5 Yr. CAGR %	32.91	29.39	21.54	15.53	12.59
Inventory, 5 Yr. CAGR %	48.22	53.37	60.62	39.78	17.81
Net Property, Plant and Equip., 5 Yr. CAGR %	43.04	47.02	31.1	22	15.01
Total Assets, 5 Yr. CAGR %	33.04	33.6	27.23	24.27	19.97
Tangible Book Value, 5 Yr. CAGR %	28.17	27.64	23.8	21.72	21.08
Common Equity, 5 Yr. CAGR %	30.7	29.48	25.55	23.71	23.4
Cash From Operations, 5 Yr. CAGR %	22.71	36.48	5.34	7.21	-0.24
Capital Expenditures, 5 Yr. CAGR %	23.72	41.55	8.33	-4.46	-5.04
Levered Free Cash Flow, 5 Yr. CAGR %	19.93	33.4	12.82	19.33	8.94
Unlevered Free Cash Flow, 5 Yr. CAGR %	19.93	33.4	12.82	19.33	8.94